Piper Sandler (PIPR) Q3 2025 Earnings Transcript Motley Fool Transcribing, The Motley FoolNovember 3, 2025 at 2:04 AM 0 Image source: The Motley Fool. Date Friday, Oct. 31, 2025, at 8 a.m. ET Call participants Chief Executive Officer — Chad R. Abraham President — Debbra Lynn Schoneman Chief Financial Officer — Katherine Patricia Clune Need a quote from a Motley Fool analyst? Email [email&160;protected] Takeaways Adjusted net revenues $455 million, up 29% compared to the yearago quarter on a nonGAAP basis, primarily driven by strong execution across all business lines in improved market conditi...
- - Piper Sandler (PIPR) Q3 2025 Earnings Transcript
Motley Fool Transcribing, The Motley FoolNovember 3, 2025 at 2:04 AM
0
Image source: The Motley Fool.
Date
Friday, Oct. 31, 2025, at 8 a.m. ET
Call participants -
Chief Executive Officer — Chad R. Abraham
President — Debbra Lynn Schoneman
Chief Financial Officer — Katherine Patricia Clune
Need a quote from a Motley Fool analyst? Email [email protected]
Takeaways -
Adjusted net revenues -- $455 million, up 29% compared to the year-ago quarter on a non-GAAP basis, primarily driven by strong execution across all business lines in improved market conditions.
Operating Margin -- 21.2% for the quarter, above the company's stated target and prior year levels.
Adjusted diluted EPS -- $3.82, exceeding the figure from the comparable period last year on a non-GAAP basis.
Corporate Investment Banking Revenues -- $292 million, representing significant year-over-year growth and marking one of the strongest third-quarter performances historically for this segment.
Advisory Revenues -- $212 million, up 13%, with 82 transactions completed; the financial services group led sector performance, supported by a resurgence in bank M&A activity.
Bank M&A Market Position -- Piper Sandler advised on six of the ten largest U.S. bank mergers closed in the quarter, ranking as the top U.S. M&A advisor to banks by announced transactions year to date.
Debt Capital Markets Advisory -- Third consecutive record year on pace, driven by higher average fees and a broader, more diversified client base.
Corporate Financing Revenues -- $80 million, the highest quarterly result since 2021; 38 financings completed, raising $14 billion in capital.
Healthcare Equity Deals -- Piper Sandler served as bookrunner on all 13 equity deals for healthcare clients this quarter.
Managing Director Headcount -- 183 investment banking Managing Directors at quarter-end, with eight new MDs added this year, including through the G-Squared acquisition and new hires in technology-related practices.
Public Finance Revenues -- $39 million from municipal financings, up 8%, supported by elevated issuance and broad-based activity across geographies and specialties.
Municipal Transactions -- 133 negotiated municipal deals executed, raising $6 billion of par for clients.
Equity Brokerage Revenues -- $54 million, down 7% sequentially from Q2 2025 as volatility moderated, but year-to-date revenues rose 8% compared to 2024.
Fixed Income Revenues -- $56 million, up 15%, with activity supported by anticipation of further interest rate cuts and balance sheet repositioning tied to M&A.
Year-to-Date Net Revenues -- $1.2 billion, an increase of 19%, with operating income of $238 million and operating margin of 19.2%.
Compensation Ratio -- 61.7% for the quarter and 62% for the first nine months, both improved compared to 2024 due to increased revenues.
Non-Compensation Expenses -- $65 million for the quarter (excluding reimbursed deal costs), up 6% year-over-year mainly from higher occupancy associated with headquarters relocation.
Income Tax Rate -- 28.8% for the quarter; year-to-date rate of 18.2% benefited from $27 million of restricted stock award vesting tax benefits, resulting in an underlying rate of 29.6% when excluded.
Shareholder Returns -- $16 million returned in the quarter, $204 million year-to-date through share repurchases and $5 per share in quarterly and special cash dividends.
Dividend Announcement -- Board approved a quarterly dividend of $0.70 per share, payable December 12 to shareholders of record as of November 25.
Outlook: Advisory Revenue -- Management expects fourth quarter advisory revenues to be similar to last year's fourth quarter.
Outlook: Corporate Financing Revenue -- Management anticipates Q4 revenues to moderate from the particularly strong third quarter.
Public Finance Outlook -- Pipeline remains strong, with Q4 revenues expected to be similar to the third quarter.
Summary
Piper Sandler (NYSE:PIPR) reported its eighth consecutive quarter of year-over-year growth, citing improved market conditions and diversified business strength. Management highlighted market share gains in financial services and healthcare advisory, including leadership positions in U.S. bank M&A deals and major biopharma capital raises. Significant expansion efforts continued, with increased hiring in the technology group and integration of newly acquired G-Squared, positioning the firm for further growth in government services and defense technology. The call detailed continued growth in debt capital markets advisory and a robust pipeline in both advisory and public finance segments. Executive commentary pointed to resilient performance in equity and fixed income businesses despite sequential slowdowns, while forward guidance signaled expectations for strength in advisory activity and seasonally moderating financing revenues through year-end.
CEO Abraham said, "We have now achieved eight consecutive quarters of year-over-year growth, underscoring our consistent execution and sustained momentum."
Public finance revenues increased 31% for the first nine months of 2025, significantly outpacing the 12% market issuance growth in par value over the same period.
President Schoneman stated that refinancing in municipal markets due to lower rates "is likely more of a 2026 phenomenon than a 2025" as clients wait for further policy clarity.
CFO Clune explained the underlying compensation ratio improvement results from managing retention and investing strategically as revenues rise.
Management cited enhanced activity and expanded average deal sizes in agented debt and private capital advisory, partially offsetting limitations in consumer-facing sectors.
Industry glossary -
Agented Debt: Debt placements where an investment bank acts as an agent between issuers and capital providers, arranging and negotiating the terms but not necessarily underwriting the risk.
Balance Sheet Restructuring: Financial advisory service provided during mergers or changing economic conditions, assisting clients—primarily banks—in optimizing asset and liability mix to improve financial resilience.
Bookrunner: The lead underwriter of a securities issuance responsible for organizing the syndicate, selling the offering, and allocating shares to investors.
G-Squared: Acquisition target specializing in government services and defense technology investment banking; now part of Piper Sandler's technology group.
Managing Director (MD): Senior executive in investment banking, typically responsible for leading client relationships, deal origination, and team management.
Private Capital Advisory: A business unit advising institutional and private equity clients on secondary sales, fund structuring, and capital solutions in private markets.
Special Districts: Niche area within municipal finance involving local government entities created for specific functions, such as infrastructure funding or service delivery.
Full Conference Call Transcript
Chad R. Abraham: Thank you, Kate. Good morning, everyone. Thank you for joining our third quarter 2025 earnings call. The market environment improved significantly in the third quarter. Equity markets reached record highs, and with lower volatility, equity underwriting meaningfully improved. Investor sentiment was helped by a calmer outlook on trade tensions and easing of monetary policy. Against this backdrop, we performed well with quarterly adjusted net revenues of $455 million, a 21.2% operating margin, and adjusted EPS of $3.82, all higher compared to the same period last year. Our strategy, anchored in deep sector expertise, market leadership, and a comprehensive suite of products across the client lifecycle, continues to resonate with clients.
We have now achieved eight consecutive quarters of year-over-year growth, underscoring our consistent execution and sustained momentum. This progress is supported by our investments in the business, the diversification of our platform, and an improving market backdrop.
During the third quarter, we generated $292 million in corporate investment banking revenues, reflecting significant growth over the prior year, and delivered one of our strongest third quarter performances on record. Our leading financial services and healthcare franchises each generated strong advisory and corporate financing revenues during the quarter. While both franchises have been perennial market leaders, we continue to expand these industry teams with additional subsector capabilities, product expertise, and connectivity with private equity clients. Our healthcare and financial services investment banking groups are among the largest teams in these sectors, led by senior bankers who have long tenures at Piper Sandler, a testament to our commitment to internal development and continuity.
Additionally, we continue to advise on some of the most significant transactions in these sectors. We advised on the largest U.S. bank M&A deal that has closed in 2025 and served as bookrunner for one of the largest biopharma capital raises in the market. As the outlook improves in both healthcare and financial services, we are well positioned to support our clients and deliver strong results for our shareholders. Specific to the advisory component of corporate investment banking, revenues for the quarter were $212 million, up 13% year-over-year as we completed 82 transactions. Sector performance was led by our financial services group.
With results bolstered by a resurgence in bank M&A activity, we advised on six of the ten largest bank mergers that closed during the third quarter, and we rank as the top advisor to banks based on the number of announced U.S. M&A transactions this year. We also had strong contributions from our healthcare, consumer, and energy, power, and infrastructure teams during the quarter.
In addition, our non-M&A advisory teams continue to drive revenue growth. In recent years, we have made substantial investments in the advisory capabilities, which include debt capital markets advisory, private capital advisory, and restructuring to expand client offerings and increase market share, especially with private equity. Our debt capital markets advisory business is on pace to deliver a third consecutive record year, reflecting higher average fees as well as a broader and more diversified client base. The combination of our industry expertise and deep relationships with a broad range of capital providers enables us to deliver best-in-class outcomes for our clients. Looking ahead, our advisory pipeline is robust and building.
The fourth quarter is typically our strongest quarter, and this year is shaping up to be no different. We expect advisory revenues for the fourth quarter of 2025 to be similar to last year's fourth quarter.
Turning to corporate financing, markets were strong throughout the quarter, and we generated $80 million of revenues, our strongest quarterly results since 2021. We completed 38 financings, raising $14 billion for corporate clients. Increased transaction activity and significantly higher average fees contributed to our strong relative performance. Revenues for the quarter were driven by healthcare and financial services. Piper Sandler served as bookrunner on all 13 of the equity deals completed for healthcare companies, driven by an improved capital raising environment for biotech clients, fueled by M&A activity, promising drug therapies, and lower interest rates. We were also active during the quarter, raising both equity and debt capital for financial services companies.
Our performance underscores the strength of our execution capabilities and the earnings potential in a favorable market environment for our core sectors. As we look ahead, our pipeline remains strong and diverse.
However, we expect fourth quarter corporate financing revenues to moderate from the particularly strong third quarter. Shifting to talent, we finished the quarter with 183 investment banking Managing Directors. Three MDs joined our technology group as we closed the G-Squared acquisition, which adds expertise in government services and defense technology. Early in the fourth quarter, we announced the hiring of two MDs focused on enterprise risk and resiliency and artificial intelligence. In total, we have added eight new MDs to our technology group this year. Building out this franchise remains a strategic priority given the sector's fee pool. Overall, our third quarter results were strong, and we are pleased with our performance year to date.
The combination of improved activity levels, strong execution across business lines, and a constructive market environment positions us well as we head into year-end.
We are entering the fourth quarter with good momentum, strong client engagement, and meaningful opportunities to gain share. With that, I will turn the call over to Debbra Lynn Schoneman to discuss our public finance and brokerage businesses.
Debbra Lynn Schoneman: Thanks, Chad. I'll begin with an update on our public finance business. Market conditions remained favorable, with elevated issuance levels, which are on track to surpass last year's record. For the third quarter of 2025, we generated $39 million of municipal financing revenues, down from the exceptionally strong second quarter, but up 8% year-over-year. We underwrote 133 municipal negotiated transactions, raising $6 billion of par value for our clients. Activity was broad-based across geographies, with strong performance from our governmental business in Texas, California, and Iowa, as well as our special districts and healthcare sectors. For the first nine months of 2025, our revenues increased 31% over last year, outpacing the market issuance growth in par value of 12%.
With record levels of issuance in the first half of this year, we saw some pull forward of activity, which has impacted the typical seasonality of this business.
Our pipeline remains strong, particularly in the specialty sectors, and we expect our fourth quarter revenues to be similar to the third quarter. Turning to our equity brokerage business, we generated $54 million of revenues for the third quarter of 2025, down 7% from the second quarter, as volatility moderated from elevated levels in April. Throughout the year, we've seen strength in our derivatives and electronic trading businesses. Our broad product capabilities, combined with the scale we have built over the last few years, have provided resiliency and upside to our performance, and our year-to-date revenues are up 8% compared to 2024.
Lastly, turning to fixed income, we generated $56 million of revenues for the third quarter of 2025, consistent with a strong second quarter and up 15% from the year-ago period. Activity was solid across most products and client verticals in anticipation of further rate cuts.
We also continued to advise on balance sheet repositioning resulting from bank M&A activity and as depository clients adjust to the changing rate environment. Our broad product capabilities, the breadth of our client base, and robust distribution allow us to provide both differentiated advice and liquidity across all aspects of the balance sheet, including loans, securities, and derivatives. Now, I will turn the call over to Katherine Patricia Clune to review our financial results and provide an update on capital use.
Katherine Patricia Clune: Thanks, Deb. My comments will address our adjusted non-GAAP financial results, which should be considered in addition to, and not a substitute for, the corresponding GAAP financial measures. For the third quarter of 2025, we generated net revenues of $455 million, operating income of $96 million, and an operating margin of 21.2%. Net income totaled $69 million, and diluted EPS was $3.82. For the first nine months of 2025, net revenues totaled $1.2 billion, operating income was $238 million, and our operating margin was 19.2%. We generated $195 million of net income and $10.86 of diluted EPS. Net revenues for the third quarter of 2025 increased 12% from the sequential quarter, driven by robust equity capital markets activity.
Net revenue for the quarter grew 29% over the third quarter of last year, driven by strong execution across all of our businesses in more accommodative markets.
For the year-to-date period of 2025, net revenues increased 19% compared to the prior year, reflecting broad-based strength across the firm. Turning to expenses, we reported a compensation ratio of 61.7% for the third quarter of 2025 and 62% for the first nine months of the year. Both ratios improved from the comparable periods of 2024, driven by increased net revenues. We continue to exercise strong operating discipline while balancing employee retention and strategic investment opportunities. For the third quarter of 2025, non-compensation expenses, excluding reimbursed deal costs, were $65 million and in line with our guided range.
Non-compensation costs for the quarter, excluding reimbursed deal expenses, increased 6% year-over-year, driven by higher occupancy costs associated with relocating our Minneapolis headquarters office. Non-compensation costs for the first nine months of 2025, excluding reimbursed deal expenses, totaled $204 million, an increase of 9% compared to the prior year period.
Moving to income tax expense, our income tax rate for the quarter was 28.8%. For the year-to-date period, income tax expense was reduced by $27 million of tax benefits related to the vesting of restricted stock awards, which resulted in an income tax rate of 18.2%. Excluding the $27 million of benefits, our effective tax rate was 29.6%. Now finishing with capital, during the quarter, we returned an aggregate of $16 million to our shareholders, of which the majority related to our quarterly dividend payment. For the first nine months of this year, we returned an aggregate of $204 million to shareholders.
This includes repurchases of approximately 362,000 shares, or $105 million, of our common stock primarily related to employee tax withholding on the vesting of restricted stock awards.
It also includes an aggregate of $99 million, or $5 per share, paid to shareholders through our quarterly and special cash dividends. Lastly, I am pleased to announce that today, the board approved a quarterly cash dividend of $0.70 per share. The dividend will be paid on December 12 to shareholders of record as of the close of business on November 25. Thank you, Kate. With that, we can now open the call for questions. If you would like to ask a question, please signal by pressing Star 1 on your telephone keypad. If you are using a speakerphone, please make sure your mute function is turned off to allow the signal to reach our equipment.
Again, press Star 1 to ask a question. We'll pause for a moment to allow everyone the opportunity to signal for questions. We will take our first question from Brendan James O'Brien with Wolfe Research.
Brendan James O'Brien: Good morning, and thanks for taking my questions. To start, I just wanted to touch on the bank M&A environment. Clearly seeing the benefits of the pickup in activity, and I believe that last quarter was the most active in terms of the number of bank deals announced in the U.S. in some time. I just wanted to get a sense as to how you'd frame the size of the opportunity that you see over the next few years within this space, and maybe what are some of the key risks that you're mindful of that could derail this momentum over the next couple of years.
Katherine Patricia Clune: Thank you. Obviously, we talked last quarter, started to see the pickup over the summer, June, July, August. Clearly, when you just look at the announced transactions in September and October, that pace has accelerated. We do expect that accelerated pace to continue. Relative to what the size of the opportunity is, obviously, depositories is only half our FSG business, and obviously FSG is a percentage of the total. We do expect a good increased depository business, and it's not just impacting sort of the M&A, but helps with the balance sheet restructurings and expect that pace to continue. What could derail that? I would say the biggest thing is just what happens with stock prices.
I would say, even though we're seeing an increased pace on a lot of the base sort of stock prices, a lot of the depository stocks haven't moved, which isn't a perfect starting point to do a transaction. It matters less if you're using equity, but I think just kind of what that base valuation is and what the market has is probably one of the bigger risks to that.
Brendan James O'Brien: That's helpful, Kate. For my follow-up, I wanted to touch on margins. You guys have done a really good job managing expenses over the past couple of years in what has been a challenging backdrop. I know you've talked about getting to 20%+ over time, but given you're already running at a 19% margin year-to-date and you have all of these tailwinds at your back as we enter into 2026, I just wanted to get a sense as to how you're thinking about the margin potential for the business as things start to normalize or in some cases really, really accelerate from here.
Katherine Patricia Clune: Good morning. Thank you for the question.
Brendan James O'Brien: Go ahead, Kate.
Katherine Patricia Clune: I'll start here. Brendan, we typically guide to things that we are quite confident in and very focused on. Similar to the discussion we have around the comp ratio range, we're certainly looking for opportunities for discipline and leverage as the top line continues to improve. Is that 20% a maximum? It certainly isn't. Will we look for opportunities to accelerate that where they present themselves? Of course, we will. That was sort of our kind of first target starting point there. To your point, we're quite pleased with where we've been performing to date, and we'll continue to look for opportunities to enhance that as we move forward.
Brendan James O'Brien: Great. Thank you for taking my questions.
Operator: We will take our next question from James Edwin Yaro with Goldman Sachs.
James Edwin Yaro: Good morning, and thanks for taking the questions. Chad, you saw a really good corporate financing print this quarter. You talked a little bit about the fourth quarter already, but maybe you could just help us think about the risks to this business from the government shutdown, whether that's temporary and if you see any more permanent impacts if this persists.
Chad R. Abraham: Yes, I've definitely been getting that question a lot, and it's a difficult one. Honestly, when I think about September and October and what happened, we haven't seen a lot of material results to revenues. I do think the next three or four weeks are going to get more painful on that front. It's a complicated question relative to corporate finance because it depends on what type of transactions there are. There are time periods that lapse when you're trying to get reviewed that if you don't, you're fine.
There are other situations where if you had done an IPO in the prior year and you're trying to do a follow-on and you're not auto-registered, then you do need to do a review.
I really do believe it's going to start both with financing and M&A starting to impact revenues if we're still talking about this a few weeks from now.
James Edwin Yaro: Okay. Really interesting. Just wanted to touch on the tech sector build-out within investment banking. You've seen strong market share gains. You just closed the G-Squared acquisition in the space. Help us think through where you are in the build-out of that sector and what are your aspirations.
Chad R. Abraham: Yeah. I mean, I would say, obviously, it's been something we've been talking about for three or four years, and we've made progress along the way. We've also made some changes to the existing group. We've added some new hires. We've done some acquisitions. I would kind of say we're halfway to where we want to be on the team. Our long-term goal is this fee pool, and just the backdrop and the sort of evolution should provide an opportunity for us to have as big a business as we have in financials and healthcare. I imagine it'll stay our number one priority the next couple of years. I sort of view it as halfway there.
Made good progress, starting to see the results in revenue, but still a lot of opportunity for growth.
James Edwin Yaro: Super helpful. Thanks a lot.
Operator: We will take our next question from Devin Patrick Ryan with Citizens.
Devin Patrick Ryan: Great. Good morning, everyone. How are you?
Chad R. Abraham: Good, Devin. Thank you.
Devin Patrick Ryan: Good. We just want to come back to the outlook for M&A advisory. Great to hear about some of the improving trends there and the expectation for a strong end of the year for revenues. It'd be great to just take a step back and think about the cadence of activity, what you've been seeing, how things trended through the third quarter, post-Labor Day, when everything kicked off, or just how to think about that trend. As you think across sectors, outside of depositories, which you talked about in depth, what are some of the big drivers that are supporting more activity and the impetus for sponsors to really more aggressively re-engage in the market? Thank you.
Chad R. Abraham: Yeah. Thanks, Devin. I would say for us, it's been a pretty steady build throughout the spring and summer and into the fall. There's no question the last couple of months, especially the pitch activity and new mandates, has increased significantly. Obviously, we already talked about just what's going on in the depository sector and just the volume there increasing pretty rapidly. I would say a couple of other things for us. Healthcare is a big sector for us, and I think we've seen we had a pretty tough year in healthcare M&A last year.
We're having a much better year this year, and frankly, just the pace of new engagements there has been really good, especially in medtech and some other areas within healthcare. I would also say just our areas that touch private equity.
I think with some of the results private equity is seeing on some of the transactions, the longer that goes, the more and more people are going to try to get liquidity to some of the things they've had in the pipeline. We're definitely seeing that. That's pretty broad. Certain parts of services, certain parts of commercial and residential services, obviously, places where tariffs don't matter. We're still having a tough time in parts of consumer. For us, things that touch private equity really touches all of our industry groups, and in those areas, we expect a pickup. Not just in M&A.
We're having another record year in debt advisory, and a big chunk of that business is working with sponsors as well.
Devin Patrick Ryan: Great. Appreciate that, Collar. One for Deb, just trying to think about some of the underlying drivers of the fixed income brokerage business. On the depository side, I guess probably a similar question that you guys got earlier on bank M&A. How should we think about what a normalization for that part of the business looks like as rates come down and there's more engagement? Is there a way to frame the revenue upside to normalization, or at least how you guys think about it?
Also, Deb, if you can just give a little bit more color for what you're seeing with municipal demand and just remind us how we should think about that trending, I guess, to the extent rates lower as well. Thanks.
Debbra Lynn Schoneman: Yeah. Great. Thanks, Devin. On the depository and fixed income, of course, as rates come down and the yield curve steepens, we, I mean, overall see increased client engagement, and that includes with depository clients as they then have an ability to reposition their balance sheets. Normalization is going to be tricky to figure out exactly what that looks like because the other thing we're seeing pick up are larger revenue events that come from balance sheet restructurings that are specifically tied to an M&A transaction. That's where we've seen some of the pickup over the last couple of quarters. Those tend to be a little bit larger transactions, and I do expect that to continue.
If you think about the commentary that Chad just discussed relative to the bank M&A business, those are very correlated as most often when these bank M&A transactions happen, we are seeing these restructurings happen with them. I would just say there's a correlation here to these larger restructurings in the M&A business. It's just a little difficult to determine the timing of them and when they'll hit. We do expect to see positive trends in our fixed income businesses as all these dynamics continue to play out in the marketplace. Specifically to the municipal side, we saw strong fund flows in the beginning of the year.
They softened a little in the second quarter, and we saw them coming back again. That's very helpful and healthy for the environment. On the high-yield side, one of the other things we're seeing is just investors having discipline.
Even with the strong fund flows, investors are discerning, I would say, in a good way. Healthy market for well-structured transactions to come. Relative to rates, which was part of your question, as those rates come down, refundings will pick up. We have seen some of that really modestly start to happen in Q3. As we look out and talk to our clients now, I think many are also choosing to wait and see what happens into next year. The refinancing activity picking up is likely more of a 2026 phenomenon than a 2025.
Devin Patrick Ryan: Excellent. Thank you. Just as a follow-up, Deb, just on the bank M&A-driven kind of balance sheet restructuring, obviously, chunky, those can be nice fees for you. Is that primarily going to be tied to deals where you're directly advising, or is there an opportunity to get involved when maybe you're not working on the M&A side of the deal, but there's just need for your expertise?
Debbra Lynn Schoneman: Great question. It is really both. We have seen some transactions where we have strong relationships where, given the approach we take, the team we have that does that work, being very well recognized in the marketplace, we are seeing some of these balance sheet restructurings that we're doing that were not associated with us on the M&A side.
For the record, Devin, we'd love a significant M&A fee, and we want to do the restructuring on everything.
Devin Patrick Ryan: Exactly.
Operator: As a reminder, if you would like to ask a question, please press star one. We will take our next question from Michael John Grondahl with Northland Securities.
Michael John Grondahl: Hey, guys. Thanks. Congrats on a nice quarter. Chad, anything else to call out on this good momentum you're seeing entering 4Q? No, I would just say probably the strongest thing we had in Q3 was just our equity financing business. Now, obviously, that was off really low levels the first couple of quarters, but that was pretty diverse. We're doing, obviously, a lot in healthcare. I would say we're seeing just more significant healthcare transactions, a few large ones where we have a significant role. That's made an impact. Obviously, that's augmented by financial services and financing both on the debt and equity side. Financing was strong.
I think there were just so many big things in Q3, which is just why we made the comment that I don't know if we'll get back to those levels in Q4, but still significantly better than where we've been.
We were obviously starting to see IPO activity and deals work, which bodes well for more IPO activity. Again, if we can get those approved and launched, will be another question with the government shutdown. The backdrop has been pretty good for a pickup in financing across a lot of our sectors. I'd call that out in addition to the comments I've already made about M&A. Perfect. Perfect. Deb, how are you feeling, maybe not so much 4Q, but just kind of 2026 in general after two Fed cuts and maybe a little bit more? How are you thinking about fixed income and municipal for 2026?
Debbra Lynn Schoneman: Yeah. I think as I was making the comments, when we see the rates coming down, more importantly, almost really the normalization of the yield curve, that'll be the thing to watch probably most importantly. You will see increased activity. One of the most important things it feels like that drives that is just more certainty. When uncertainty enters, the investors pause a bit. I think it's a favorable environment from that perspective. Really, again, rate cuts, but more importantly, a normalization of the yield curve.
Michael John Grondahl: Got it. Got it. Congrats on 3Q, and good luck the rest of the way this year.
Debbra Lynn Schoneman: Thanks, Mike.
Chad R. Abraham: Thank you.
Operator: We will take a follow-up question from James Edwin Yaro with Goldman Sachs.
James Edwin Yaro: Thanks for taking the follow-up. Chad, would it be possible for you to just comment on the momentum in your non-M&A advisory business, and maybe if you could just size how much this contributed in the quarter?
Chad R. Abraham: Yeah. We still don't disclose the % of sort of non-M&A advisory. We are looking at that as it becomes more and more significant. What I would say is, the last three years, the pace of growth has been more significant than M&A. Just as a reminder, there's multiple pieces to that. We obviously talked about the agented debt business that we do a lot with sponsors, and that's just growing significantly as there's just so many providers of that capital. I would say we're doing larger and larger deals there.
A lot of our deals used to be $50 million, $100 million, $150 million there, and now we're seeing opportunities in sort of agented debt where we're doing $400 million, $500 million, $600 million raises, which makes a big difference. Another piece for us is obviously restructuring.
I would say that business is, the longer we get into it, the more and more we're doing with more industry teams. In general, the market backdrop there probably has that as a flatter market. Given that's a small fee pool for us, we still feel like we can grow share. Obviously, another big piece for us is we're having success with the private capital advisory and the Avidity team we added. Closed a significant secondary transaction, and the more wins we get there, the more stories we have with clients. All of those make up the lion's share of that business, and I would say that business continues to grow faster than M&A.
James Edwin Yaro: Thanks for the color.
Operator: There are no further questions at this time. I will turn the conference back to Mr. Abraham for any additional or closing remarks.
Chad R. Abraham: All right. Thanks, everyone that joined us this morning. We look forward to updating you on our fourth quarter and full year 2024 results early next year. Have a great day and happy Halloween.
Operator: This concludes today's call. Thank you for your participation. You may now disconnect.
Where to invest $1,000 right now
When our analyst team has a stock tip, it can pay to listen. After all, Stock Advisor's total average return is 1,072%* — a market-crushing outperformance compared to 194% for the S&P 500.
They just revealed what they believe are the 10 best stocks for investors to buy right now, available when you join Stock Advisor.
See the stocks »
*Stock Advisor returns as of October 27, 2025
This article is a transcript of this conference call produced for The Motley Fool. While we strive for our Foolish Best, there may be errors, omissions, or inaccuracies in this transcript. Parts of this article were created using Large Language Models (LLMs) based on The Motley Fool's insights and investing approach. It has been reviewed by our AI quality control systems. Since LLMs cannot (currently) own stocks, it has no positions in any of the stocks mentioned. As with all our articles, The Motley Fool does not assume any responsibility for your use of this content, and we strongly encourage you to do your own research, including listening to the call yourself and reading the company's SEC filings. Please see our Terms and Conditions for additional details, including our Obligatory Capitalized Disclaimers of Liability.
The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.
Source: "AOL Money"
Source: Money
Published: November 02, 2025 at 11:19PM on Source: TRENDY MAG
#ShowBiz#Sports#Celebrities#Lifestyle